Volume 54, Issue 5, Pages (November 1998)

Slides:



Advertisements
Similar presentations
An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies 
Advertisements

Volume 91, Issue 1, Pages (January 1987)
Behzad Najafian, MD, Agnes B. Fogo, MD, Mark A. Lusco, MD, Charles E
Volume 57, Issue 2, Pages (October 2000)
Mark A. Lusco, MD, Agnes B. Fogo, MD, Behzad Najafian, MD, Charles E
Volume 54, Issue 2, Pages (August 1998)
Paraneoplastic glomerulopathies: New insights into an old entity
Volume 72, Issue 10, Pages (November 2007)
Volume 75, Issue 9, Pages (May 2009)
Anti-glomerular basement membrane disease
Retransplantation in Alport post-transplant anti-GBM disease
Volume 61, Issue 5, Pages (May 2002)
Respiratory syncytial virus nephropathy in rats
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Glomerular disease related to anti-VEGF therapy
Volume 75, Issue 10, Pages (May 2009)
Idiopathic Pulmonary Hemorrhage
Volume 62, Issue 1, Pages (July 2002)
Volume 67, Issue 1, Pages (January 2005)
Non-amyloid fibrils in heavy chain deposition disease
Volume 63, Issue 1, Pages (January 2003)
An Uncommon Cause of Membranous Glomerulonephritis
Volume 54, Issue 6, Pages (January 1998)
Volume 59, Issue 4, Pages (April 2001)
Volume 61, Issue 5, Pages (May 2002)
Volume 56, Issue 3, Pages (September 1999)
Volume 64, Issue 4, Pages (October 2003)
A new mouse model of immune-mediated podocyte injury
Volume 58, Issue 5, Pages (November 2000)
Volume 56, Issue 2, Pages (August 1999)
Volume 66, Issue 1, Pages (July 2004)
Nrf2-deficient female mice develop lupus-like autoimmune nephritis1
Volume 61, Issue 2, Pages (February 2002)
Volume 63, Issue 4, Pages (April 2003)
Volume 67, Issue 5, Pages (May 2005)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 68, Issue 3, Pages (September 2005)
Volume 61, Issue 6, Pages (June 2002)
Volume 59, Issue 6, Pages (June 2001)
Volume 67, Issue 2, Pages (February 2005)
Volume 54, Issue 2, Pages (August 1998)
Renal vascular sclerosis is associated with inherited thrombophilias
Volume 58, Issue 6, Pages (December 2000)
Diffuse Alveolar Hemorrhage Temporally Related to Cocaine Smoking
Volume 53, Issue 5, Pages (May 1998)
Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals  Zhao Cui, Ming-hui Zhao,
Volume 66, Issue 5, Pages (November 2004)
C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis  Gopala K. Rangan, Jeffrey W. Pippin, William.
Volume 66, Issue 4, Pages (October 2004)
Volume 65, Issue 1, Pages (January 2004)
Volume 57, Issue 1, Pages (January 2000)
Volume 63, Issue 1, Pages (January 2003)
Volume 54, Issue 3, Pages (September 1998)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
C3 Glomerulonephritis: A Rare Etiology of the Pulmonary Renal Syndrome
Aminopeptidase A: A nephritogenic target antigen of nephrotoxic serum
Red cell traverse through thin glomerular basement membranes
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
Antiglomerular basement membrane disease with normal renal function
Volume 80, Issue 7, Pages (October 2011)
Laminin-8/9 is synthesized by rat glomerular mesangial cells and is required for PDGF- induced mesangial cell migration  Kim Hansen, Christine K. Abrass 
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 63, Issue 1, Pages (January 2003)
Volume 65, Issue 6, Pages (June 2004)
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 58, Issue 5, Pages (November 2000)
Unmasking a unique glomerular lesion
Volume 72, Issue 4, Pages (August 2007)
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Tissue proteomics: a new investigative tool for renal biopsy analysis
Presentation transcript:

Volume 54, Issue 5, Pages 1550-1561 (November 1998) Experimental Goodpasture's syndrome in Wistar-Kyoto rats immunized with α3 chain of type IV collagen  Mauro Abbate, Raghuram Kalluri, Daniela Corna, Naoto Yamaguchi, Robert T. McCluskey, Billy G. Hudson, Giuseppe Andres, Carla Zoja, Giuseppe Remuzzi  Kidney International  Volume 54, Issue 5, Pages 1550-1561 (November 1998) DOI: 10.1046/j.1523-1755.1998.00153.x Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 1 Photomicrographs of cryostat sections of kidneys taken from rats immunized with 20 μg α3(IV) NC1 monomer (A), 25 μg α3(IV) NC1 dimer (B), or 400 μg α3(IV) NC1 hexamer (C), and from a control rat (D). Sections were stained for rat IgG by direct immunofluorescence. Rat IgG is distributed in linear pattern along the glomerular basement membranes in the glomeruli from rats injected with the bovine α3(IV) NC1 peptides (A, B, C). No linear deposits of rat IgG are present in control kidney (D) (×500). Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 2 Pulmonary effects of immunization with bovine α3(IV) NC1 dimer in rats. (A) Normal lung structure in a control rat (H&E, ×150). (B) Section of lung from a rat immunized with 20 μg α3(IV) NC1 dimer exhibiting foci of hemorrhagic pneumonitis and mild thickening of alveolar septa (PAS; ×150. (C) Rat immunized with 50 μg α3(IV) NC1 dimer. Red blood cells and macrophages containing hemosiderin are present in alveolar spaces (H&E, ×300). (D) Red blood cells and iron-containing macrophages are present in the alveolar spaces in the lung from a rat immunized with 100 μg α3(IV) NC1 dimer. The inset shows macrophages containing crystals of hemosiderin (Gomori's Prussian Blue; ×300; inset ×800). Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 3 Rat immunized with 50 μg α3(IV) NC1 dimer. Electron micrograph of an hemorrhagic area of lung showing red cells, in alveolar spaces, electron dense crystals of hemosiderin (arrows), and inflammatory cells (asterisks) (uranyl acetate and lead citrate; ×3,300). Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 4 Immunofluorescence micrographs of sections of lungs taken from rats injected with α3(IV)NC1 dimer or vehicle, stained for rat IgG. No linear deposits of IgG are seen in the lungs of rats injected with 25 μg α3(IV)NC1 dimer (A) or with vehicle (B). (C) Linear deposits of IgG focally in alveolar capillary walls of a rat immunized with the highest dose (100 μg) of α3(IV)NC1 dimer (×600). Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Figure 5 Specificity of kidney-bound antibodies from rats immunized with α3(IV) NC1 dimer (groups VI and VII) or hexamer (group IX) and control (group III). Samples were assayed in triplicate for each rat. Bars represent three rats per group. Symbols are: (□) control; (▪) 25 μg dimer; () 50 μg dimer; (□) hexamer. Values are mean ± se. Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions

Kidney International 1998 54, 1550-1561DOI: (10. 1046/j. 1523-1755 Kidney International 1998 54, 1550-1561DOI: (10.1046/j.1523-1755.1998.00153.x) Copyright © 1998 International Society of Nephrology Terms and Conditions